Navigation Links
MannKind to Present at the Morgan Stanley Healthcare Conference
Date:4/28/2008

VALENCIA, Calif., April 28 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Morgan Stanley Healthcare Conference on Wednesday, April 30, 2008 at 8:30 AM ET at The Ritz-Carlton, Key Biscayne, Florida.

Interested parties can access a link to the live web cast of the presentation in the Investor Relations section of the Company's website at http://www.mannkindcorp.com. A replay of each presentation will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.


'/>"/>
SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
2. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
3. MannKind Corporation Response to Recent Market Events
4. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
5. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
6. MannKind to Present at the Wachovia 2008 Healthcare Conference
7. MannKind to Present at the Piper Jaffray Healthcare Conference
8. MannKind Announces Positive Results from a Phase 1a Study of a GLP-1 Formulation
9. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
10. MannKind to Present at the UBS Global Life Sciences Conference
11. MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at the 33rd Annual Deutsche Bank Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...IK,Iceland,November24/PRNewswire-FirstCall/--deCOD...rovalofallofits,"firstday"motionsbytheU.S.Bankrupt...rt").deCODElastweekfiledavoluntarypetitionfor,reli...hthe,BankruptcyCourt. , TheordersissuedbytheB...tsbusinessduringtheChapter11proceedings.Inparticul...
(Date:11/24/2009)... The FBI recently approved the Promega P...icipating in or generating DNA records for the Nat... Madison, WI USA (PRWEB) -- The FBI recently appro...use by laboratories participating in, or generatin...NDIS). NDIS currently contains more than seven mil...
(Date:11/24/2009)...CITY,Calif.,Nov.24/PRNewswire-FirstCall/--GenomicH...ott,GenomicHealth,sExecutiveChairman,willpresentat...YorkCityonTuesday,December1,2009at10:00a.m.ET. ,...thepresentation,visittheInvestorRelationssectionof...alth.com .Pleaseconnecttothewebsiteatleast15minute...
(Date:11/23/2009)...TY, Nov. 23, 2009 In a provocative new study, a U...bon dioxide emissions the major cause of global w...onomy collapses or society builds the equivalent o...ooks unlikely that there will be any substantial n...tion in carbon dioxide emission rates," says the n...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...- No Material Impact on Business Expected -, HOUS...ay announced that, based on an initial assessment,...d no damage as a result of Hurricane,Ike., Howeve...eral more days.,Therefore, the Company is currentl..., Cyberonics maintains sufficient product invento...
...WALTHAM, Mass., Sept. 15 Inverness Medical,Innova...ear-patient,diagnostics, monitoring and health man....77 per share on its Series B Convertible Perpetua...ill be paid in shares of Series B,stock in an amou...vided by,(b) 97% of the average of the volume-weig...
...SAN MARINO, Calif., Sept. 15 Epeius Biotechnologi...ead product in development,for metastatic cancer, ...ished by the Journal of the National Cancer Instit... Vickie Brower, describes recent advances,and new ...ere small,molecules and proteins have failed. Note...
Other Biology Technology:Cyberonics Provides Update on Business Operations Following Hurricane Ike 2Cyberonics Provides Update on Business Operations Following Hurricane Ike 3Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock 2Epeius Biotechnologies' Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal 2
(Date:11/23/2009)...s have existed for 360 million years and survived ...s is threatening to make many of them extinct, acc...robiology Today . , The fungus, Batrachochytri... with waves of amphibian extinctions in Central Am...d infects over 350 amphibian species by penetratin...
(Date:11/23/2009)...ral Medical Sciences (NIGMS), part of the National...llion for grants in scientific areas it identified...GO grant program to stimulate biomedical research ...an Recovery and Reinvestment Act (Recovery Act). ,...ve a significant impact on a field of biomedical s...
(Date:11/23/2009)...ethon Institute for Child Health Research has foun...onsumption in pregnancy affects child behaviour in...shed online in the international journal Addictio...sis was drawn from a random sample of more than 20...ths after the baby,s delivery, and were then follo...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3New study links alcohol in pregnancy to child behavior problems 2Springer launches MyCopy service for eBook users 49628 1Springer launches MyCopy service for eBook users 49628 2Fish protein link to controlling high blood pressure new study 49626 1Fish protein link to controlling high blood pressure new study 49626 2Faculty of 1000 praised by Wellcome Trust 8954 1
...rneys are among the longest in the animal kingdom .... An international team of scientists led by the U...ecrets of endangered loggerhead turtles in West Af...for strategies to protect them. , In a paper in th...n international team describe how they used satell...
...s at the University of York have made a huge leap ... , A research group in the Department of Biology h... bacteria use proteins to conduct a type of biolog... try to kill each other when resources are scarce ...re potent toxins. , The research led by Profess...
...to identify potential drugs that interfere with th...disease and similar health problems led scientists...erimental approach that allow them to see multiple...heir report on the work is published July 21 in th...rug development operations test chemicals on enzym...
Other Biology News:How satellite tracking revealed the migratory mysteries of endangered Atlantic loggerhead turtles 2Hopkins researchers develop new tool to watch real-time chemical activity in cells 2Hopkins researchers develop new tool to watch real-time chemical activity in cells 3
Rabbit Anti-C/EBPalpha Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Human VEZT Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Ia Antigen Monoclonal Antibody, Biotin Conjugated, Clone CIa from Abcam
Rabbit Anti-TAK1, phospho (Thr184 / Thr187) Monoclonal Antibody, Unconjugated, Clone 90C7 from Cell Signaling Technology
Biology Products: